Preferred Name |
Quinapril |
|
Synonyms |
QUINAPRIL Quinapril |
|
Definitions |
A prodrug and non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Quinapril is hydrolized into its active form quinaprilat, which binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This abolishes the potent vasoconstrictive actions of angiotensin II and leads to vasodilatation. Quinapril also causes a decrease in angiotensin II-induced aldosterone secretion by the adrenal cortex, thereby promoting diuresis and natriuresis, and increases bradykinin levels. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62074 |
|
CAS_Registry |
85441-61-8 |
|
CHEBI_ID |
CHEBI:8713 |
|
Chemical_Formula |
C25H30N2O5 |
|
code |
C62074 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A prodrug and non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Quinapril is hydrolized into its active form quinaprilat, which binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This abolishes the potent vasoconstrictive actions of angiotensin II and leads to vasodilatation. Quinapril also causes a decrease in angiotensin II-induced aldosterone secretion by the adrenal cortex, thereby promoting diuresis and natriuresis, and increases bradykinin levels. |
|
FDA_UNII_Code |
RJ84Y44811 |
|
FULL_SYN |
QUINAPRIL Quinapril |
|
Has_Salt_Form | ||
label |
Quinapril |
|
Legacy Concept Name |
Quinapril_Base |
|
Preferred_Name |
Quinapril |
|
prefixIRI |
Thesaurus:C62074 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0072857 |
|
subClassOf |